Schedule 13D ownership disclosure
CAMP4 Therapeutics Corp.
Common Stock, $0.0001 par value per share · CUSIP: 13463J101
Event date: 2025-09-11
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Enavate Sciences GP, LLCReported CIK 0001953107
Shares: 3,785,802.00 · Class: 8.1%
- Everest Aggregator, LPReported CIK 0002040426
Shares: 3,785,802.00 · Class: 8.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001953107-25-000007
- Form type
- SCHEDULE 13D/A
- Filer
- Camp4 Therapeutics Corp
- CIK
- CIK 1736730
- Filed
- Sep 15, 2025
- Reporting period
- Sep 11, 2025
- Description
- Schedule 13D beneficial ownership